LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

LHX3 is an advanced-stage prognostic biomarker and metastatic oncogene in hepatocellular carcinoma

Published:2019-09-05 Issue:1 Volume:26 Page:31-39
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Huang Bo¹¹,Tian Zhan-Fei²³¹,Li Lu-Feng²,Fan Yi²,Yin Hao-Yang²,Li Yan⁴,Mao Qing²,You Zhong-Lan¹²

Affiliation:

1. The People’s Hospital of Shapingba District in Chongqing, Chongqing, China

2. Institute of Infectious Diseases, Southwest Hospital, Army Medical University, Chongqing, China

3. Department of Infectious Diseases, Chinese PLA Central Theater General Hospital, Wuhan, Hubei, China

4. Chongqing University Cancer Hospital, Chongqing, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference28 articles.

1. Global cancer statistic, 2012;Torre;CA Cancer J Clin,2015

2. Hepatocellular carcinoma from epidemiology to prevention: translating knowledgeinto practice;Singal;Clin Gastroenterol Hepatol,2015

3. Low frequency of peripheral lymphocyte in chronic hepatitis B patients predicts poor progression to hepatocellular carcinoma;Li;J Clin Lab Anal,2016

4. Hepatocellular carcinoma;Llovet;Lancet,2003

5. New therapies for hepatocellular carcinoma;Avila;Oncogene,2006

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning to comprehensively reveal signature genes and regulatory mechanisms in pituitary tumors;2023-05-10

2. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer;Cancer Innovation;2022-09-26

3. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma;Oxidative Medicine and Cellular Longevity;2022-09-19

4. Transglutaminase 3 expression in hepatocellular carcinoma patients: Correlation with tumor features and survival profile;Clinics and Research in Hepatology and Gastroenterology;2022-03

5. Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook;Journal of Hepatocellular Carcinoma;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3